Wanbury
Wanbury Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic medicines. Founded in 2000, the company has established a strong presence in various operational regions, including Asia, Europe, and North America. With a diverse portfolio that includes formulations across multiple therapeutic areas, Wanbury is recognised for its commitment to quality and innovation. The company’s core products encompass a range of oral solid dosages, injectables, and specialty pharmaceuticals, setting it apart through rigorous adherence to international standards. Wanbury has achieved significant milestones, including regulatory approvals from major global health authorities, which solidify its market position. As a trusted name in the pharmaceutical sector, Wanbury continues to contribute to healthcare advancements while ensuring accessibility to essential medications.
DitchCarbon Score
How does Wanbury's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wanbury's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wanbury's reported carbon emissions
In 2024, Wanbury reported total carbon emissions of approximately 633,837,000 kg CO2e across all scopes. This includes about 56,254,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and approximately 31,632,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, around 633,837,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. Despite the significant emissions figures, Wanbury has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets suggests that the company may still be in the early stages of formalising its climate commitments. As the industry increasingly prioritises sustainability, it will be crucial for Wanbury to establish clear goals and strategies to address its carbon emissions effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2024 | |
|---|---|
| Scope 1 | 56,254,000 |
| Scope 2 | 31,632,000 |
| Scope 3 | 633,837,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wanbury is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
